Literature DB >> 16288128

Delirium associated with baclofen withdrawal: a review of common presentations and management strategies.

Raphael J Leo1, Daniel Baer.   

Abstract

The authors reviewed 23 published cases of psychiatric symptoms in association with baclofen withdrawal. Delirium, and not other functional psychiatric conditions, arose secondarily from abrupt baclofen cessation. Vulnerability to baclofen-withdrawal delirium appeared to be greater in individuals who received chronic baclofen therapy. Baclofen-withdrawal delirium can be difficult to distinguish from delirium of other etiologies, and unrecognized and inadequately treated baclofen-withdrawal delirium is associated with significant morbidity and mortality. Complete resolution of delirium symptoms was possible with reinstatement of baclofen. The clinical management of patients experiencing baclofen-withdrawal delirium includes supportive interventions to reduce complications of delirium until symptoms resolve.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288128     DOI: 10.1176/appi.psy.46.6.503

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  20 in total

Review 1.  Potential therapeutic interventions for fragile X syndrome.

Authors:  Josien Levenga; Femke M S de Vrij; Ben A Oostra; Rob Willemsen
Journal:  Trends Mol Med       Date:  2010-09-21       Impact factor: 11.951

2.  Oral Baclofen Withdrawal Resulting in Progressive Weakness and Sedation Requiring Intensive Care Admission.

Authors:  Bret D Alvis; Christopher M Sobey
Journal:  Neurohospitalist       Date:  2016-03-14

Review 3.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

Review 4.  Drug deprescription-withdrawal risk, prevention, and treatment.

Authors:  Madison K Bangert; Gabriel M Aisenberg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-12-20

5.  The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.

Authors:  J M Wierońska; M Kusek; K Tokarski; J Wabno; W Froestl; A Pilc
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 6.  Acute intrathecal baclofen withdrawal: a brief review of treatment options.

Authors:  James C Ross; Aaron M Cook; Gary L Stewart; Brenda G Fahy
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

7.  Transient alteration of consciousness in spinal cord injury secondary to Baclofen use: a case report.

Authors:  Thomas John Pisano; Jessica Ace; Beverly Hon
Journal:  Spinal Cord Ser Cases       Date:  2022-05-21

8.  Roux-en-Y gastric bypass for intractable biliary reflux in an individual with incomplete tetraplegia.

Authors:  Deborah Caruso; Donald Tower; Lance Goetz
Journal:  J Spinal Cord Med       Date:  2014-09-22       Impact factor: 1.985

Review 9.  Baclofen therapeutics, toxicity, and withdrawal: A narrative review.

Authors:  Jia W Romito; Emily R Turner; John A Rosener; Landon Coldiron; Ashutosh Udipi; Linsey Nohrn; Jacob Tausiani; Bryan T Romito
Journal:  SAGE Open Med       Date:  2021-06-03

Review 10.  GABAergic Mechanisms Can Redress the Tilted Balance between Excitation and Inhibition in Damaged Spinal Networks.

Authors:  Graciela Lujan Mazzone; Atiyeh Mohammadshirazi; Jorge Benjamin Aquino; Andrea Nistri; Giuliano Taccola
Journal:  Mol Neurobiol       Date:  2021-04-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.